Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR): A Randomized, Double-Blind, Placebo-Controlled Trial With Incomplete Crossover

NCT02396238 is registered in ClinicalTrials.gov with Cytori Therapeutics as lead sponsor.

NCT NCT02396238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02396238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR): A Randomized, Double-Blind, Placebo-Controlled Trial With Incomplete Crossover
Lead sponsor
Cytori Therapeutics
Phase
Not applicable
Overall status
Completed
Start date
May 15, 2015
Completion date
May 22, 2018
Enrollment
88 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

raynaud phenomena, raynaud's disease, scleroderma, systemic sclerosis